Search results

62 results

Sorted by Relevance . Sort by Date

Guidance Remove Guidance filter
Discontinued Remove Discontinued filter
In consultation Remove In consultation filter
Technology appraisal guidance Remove Technology appraisal guidance filter
Medical technologies guidance Remove Medical technologies guidance filter
NICE guidelines Remove NICE guidelines filter
Clinical guidelines Remove Clinical guidelines filter
Diagnostics guidance Remove Diagnostics guidance filter

Venous thromboembolism (VTE) - ximelagatran [ID396]

Discontinued [GID-TAG378]

Type

Technology appraisal guidance

Status

Discontinued
Dapagliflozin, empagliflozin and sotagliflozin for treating type 1 diabetes [ID1217]

Discontinued [GID-TA10236]

Type

Technology appraisal guidance

Status

Discontinued
Falls - faller's clinics [ID103]

Discontinued [GID-TAG375]

Type

Technology appraisal guidance

Status

Discontinued
Renal cell carcinoma (second line metastatic) - pazopanib [ID70]

Discontinued [GID-TAG398]

Type

Technology appraisal guidance

Status

Discontinued
Diabetic foot ulcers - new treatments [ID381]

Discontinued [GID-TAG371]

Type

Technology appraisal guidance

Status

Discontinued
Venous leg ulcers - new treatments [ID394]

Discontinued [GID-TAG370]

Type

Technology appraisal guidance

Status

Discontinued
Bone loss (therapy-induced) in non-metastatic breast cancer - denosumab [ID83]

Discontinued [GID-TAG411]

Type

Technology appraisal guidance

Status

Discontinued
LJ TEST

Discontinued [GID-TA10462]

Type

Technology appraisal guidance

Status

Discontinued
Breast cancer (advanced or metastatic) hormone-sensitive - lapatinib [ID115]

Discontinued [GID-TAG404]

Type

Technology appraisal guidance

Status

Discontinued
Multiple sclerosis - sativex [ID387]

Discontinued [GID-TAG368]

Type

Technology appraisal guidance

Status

Discontinued
Bempegaldesleukin with nivolumab for untreated unresectable or metastatic melanoma

Discontinued [GID-TA10970]

Type

Technology appraisal guidance

Status

Discontinued
Durvalumab for treating metastatic urothelial bladder cancer after chemotherapy ID1172

Discontinued [GID-TA10394]

Type

Technology appraisal guidance

Status

Discontinued

Filter (8 in use)

Type 1 selected

Status 2 selected

Last updated

Guidance programme 5 selected

62 results

Venous thromboembolism (VTE) - ximelagatran [ID396]

Dapagliflozin, empagliflozin and sotagliflozin for treating type 1 diabetes [ID1217]

Falls - faller's clinics [ID103]

Renal cell carcinoma (second line metastatic) - pazopanib [ID70]

Diabetic foot ulcers - new treatments [ID381]

Venous leg ulcers - new treatments [ID394]

Bone loss (therapy-induced) in non-metastatic breast cancer - denosumab [ID83]

LJ TEST

Breast cancer (advanced or metastatic) hormone-sensitive - lapatinib [ID115]

Multiple sclerosis - sativex [ID387]

Bempegaldesleukin with nivolumab for untreated unresectable or metastatic melanoma

Durvalumab for treating metastatic urothelial bladder cancer after chemotherapy ID1172